SBFM Sunshine Biopharma, Inc.: Bozor kapitallashuvining balans qiymatiga nisbati

Sunshine Biopharma (SBFM) - korporativ logo

Bozor qiymatining balans qiymatiga nisbati koeffitsiyentidagi o'zgarishlar tebranishlarni namoyish etmoqda, chunki Sunshine Biopharma (SBFM) muvaffaqiyati generik dori vositalari savdosi va xomashyo xarajatlariga bog'liq. 0.01 qiymati ushbu holatni aks ettiradi. Fundamental salohiyat noyob anti-tumor molekulalariga bo'lgan elastik bo'lmagan talabga asoslangan, garchi joriy mRNA aktivlari bo'yicha R&D tadqiqotlari moliyaviy restrukturizatsiya tufayli hali erta bosqichda qolgan bo'lsa-da.

Sunshine Biopharma (SBFM) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 28.10.2026gacha

SBFM (Sunshine Biopharma Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Sunshine Biopharma, Inc.|SBFM - Konsensus maqsadli narx
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Sunshine Biopharma|SBFM - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Sunshine Biopharma|SBFM - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati sunshinebiopharma.com|SBFM - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Sunshine Biopharma|SBFM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Sunshine Biopharma|SBFM - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Sunshine Biopharma
Fundamental baholash:SBFM (Sunshine Biopharma, Inc.)
Sunshine Biopharma Inc. tayyor mahsulotlari

Investorlar Sunshine Biopharma (SBFM) salohiyatini sof aktivlar qiymati prizmasi orqali bahlamoqdalar. Ushbu koeffitsient biznesning bozor qiymatini uning balans kapitali bilan solishtirib, kompaniya uchun to'langan premium miqdorini aniqlaydi. Kompaniyaning joriy P/BV koeffitsiyenti tahlili bozor kutuvlari va haqiqiy garovlar o'rtasidagi tafovutni ochib beradi. Tasdiqlangan dori vositalariga ega bo'lmagan biofarmatsevtika startapi uchun bunday metrika spekulyativ premiumni aks ettiradi. Moliyalashtirish yetishmovchiligi bilan bog'liq yuqori xavf ushbu ko'rsatkichni moliyaviy barqarorlikning muhim belgisiga aylantiradi.

Asosiy raqobatchilar

ONC (BeiGene Ltd) - Bozor qiymatining balans qiymatiga nisbati|halozyme.com (HALO) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBIT|CVM (CEL-SCI Corporation) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi ostherapies.com OSTX|Kapitallashuvning sof aktivlarga nisbati RADX (Radiopharm Theranostics)|Artiva Biotherapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Adlai Nortye Limited (ANL) - Bozor qiymatining balans qiymatiga nisbati|VERU: Kapitallashuvning balans qiymatiga nisbati|Tempest Therapeutics - Bozor qiymatining balans qiymatiga nisbati|Xilio Therapeutics (XLO) - Balans qiymatiga nisbatan bozor kapitallashuvi|RENB - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Mural Bio|KAPA (Kairos Pharma Ltd) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi OKUR (onkuretherapeutics.com)|GDTC - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Curis Inc. CRIS|APLM (Apollomics Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Tharimmune Inc (THAR) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati advanbiomed.com ADVB|Genprex Inc (GNPX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati Calidi Biotherapeutics Inc.|Bozor qiymatining balans qiymatiga nisbati Xenetic Bio|SLRX (Salarius Pharmaceuticals, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi PPBT (Purple Biotech Ltd)|AONC: Bozor qiymatining balans qiymatiga nisbati|BeiGene Ltd - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Checkpoint Therapeutics|ELEV - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati icadmed.com ICAD|Ikena Oncology (IKNA) - Balans qiymatiga nisbatan bozor qiymati|NTBL (Notable Labs Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati VIRX|MorphoSys AG (MOR) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati NAYA (nayabiosciences.com)|Ascentage Pharma - Bozor qiymatining balans qiymatiga nisbati